Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Stroup

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Epilepsia|November 23, 2006
Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizuresDaniel L Drane, David J Williamson, Elizabeth S Stroup, et al.
Molecular Psychiatry|September 2, 2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychoticsJ L McClay, D E Adkins, K Aberg, et al.
Schizophrenia Research|October 4, 2005
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controlsDonald C Goff, Lisa M Sullivan, Joseph P McEvoy, et al.
The Pharmacogenomics Journal|October 6, 2010
Genome-wide association study of antipsychotic-induced QTc interval prolongationK Aberg, D E Adkins, Y Liu, et al.
Molecular Psychiatry|March 3, 2010
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsD E Adkins, K Aberg, J L McClay, et al.
Molecular Psychiatry|March 19, 2008
Genomewide association for schizophrenia in the CATIE study: results of stage 1P F Sullivan, D Lin, J-Y Tzeng, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Epilepsia|November 23, 2006
Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizuresDaniel L Drane, David J Williamson, Elizabeth S Stroup, et al.
Molecular Psychiatry|September 2, 2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychoticsJ L McClay, D E Adkins, K Aberg, et al.
Schizophrenia Research|October 4, 2005
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controlsDonald C Goff, Lisa M Sullivan, Joseph P McEvoy, et al.
The Pharmacogenomics Journal|October 6, 2010
Genome-wide association study of antipsychotic-induced QTc interval prolongationK Aberg, D E Adkins, Y Liu, et al.
Molecular Psychiatry|March 3, 2010
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsD E Adkins, K Aberg, J L McClay, et al.
Molecular Psychiatry|March 19, 2008
Genomewide association for schizophrenia in the CATIE study: results of stage 1P F Sullivan, D Lin, J-Y Tzeng, et al.
Pageof 6